AIMP1 and Lymphatic Metastasis: Increased levels of EMAP-II expression was significantly correlated with presence of metastasis (P=0.05); increasing Dukes' stage (P<0.01); presence of lymphatic metastasis (P=0.05); vascular metastasis (P=0.01); lymph node metastasis (P<0.01); death (P=0.03) and development of recurrence (P=0.01).